Pulsenmore appoints David Woods as chief commercial officer

Pulsenmore appointed medtech veteran David Woods as chief commercial officer to scale its U.S. commercial operations. Woods previously served as chief commercial officer at Creo Medical. He also held senior roles at PENTAX Medical, including president and CEO of PENTAX Medical Americas. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pulsenmore Ltd. published the original content used to generate this news brief via (Ref. ID: 202610130700PR_NEWS_USPR_____IO70676) on October 13, 2026, and is solely responsible for the information contained therein. (C)